Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 208 to 257 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 208\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent s-phase kinase-associated protein 1a (cyclin a/cdk2-associated protein p19) (p19a) (p19skp1) (rna polymerase ii elongation factor-like protein) (organ of corti protein 2) (ocp-ii protein) (ocp-2) (transcription elongation factor b) (siii). [source:swissprot;acc:p34991]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 285.684\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 252.234\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.13261\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 209\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent f-box protein fbw7 isoform 2; archipelago, drosophila, homolog of; f-box protein fbw7; f-box protein sel-10; homolog of c elegans sel-10. [source:refseq;acc:nm\_018315]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 210\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cullin homolog 2 (cul-2). [source:swissprot;acc:q13617]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 211\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent presenilin 1 (ps-1) (s182 protein). [source:swissprot;acc:p49768]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 212\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cullin homolog 1 (cul-1). [source:swissprot;acc:q13616]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 213\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pallidin; pallid (mouse) homolog, pallidin. [source:refseq;acc:nm\_012388]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 210.693\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 186.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.127\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 214\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lag1 longevity assurance homolog 2 isoform 1; l3 pigment; tumor metastasis-suppressor. [source:refseq;acc:nm\_022075]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 191.644\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 170.192\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12605\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 215\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, cardiac muscle alpha isoform (myhc-alpha). [source:swissprot;acc:p13533]\vspace{3pt}}&\multirow{9}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 112\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 126\vspace{3pt}}}&\multirow{9}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.125\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 216\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, skeletal muscle, fetal (myosin heavy chain iib) (myhc-iib). [source:swissprot;acc:q9y623]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 217\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, skeletal muscle, perinatal (myhc-perinatal). [source:swissprot;acc:p13535]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 218\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, skeletal muscle, adult 2 (myosin heavy chain iia) (myhc-iia). [source:swissprot;acc:q9ukx2]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 219\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, fast skeletal muscle, embryonic (muscle embryonic myosin heavy chain) (smhce). [source:swissprot;acc:p11055]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 220\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, skeletal muscle, adult 1 (myosin heavy chain iix/d) (myhc-iix/d). [source:swissprot;acc:p12882]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 221\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, cardiac muscle beta isoform (myhc-beta). [source:swissprot;acc:p12883]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 222\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dj756n5.1.1 (continues in em:al133324 as dj1161h23.3) (fragment). [source:sptrembl;acc:q9h430]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 223\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin heavy chain, skeletal muscle, extraocular (myhc-eo). [source:swissprot;acc:q9ukx3]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 224\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent oligopeptide transporter, kidney isoform (peptide transporter 2) (kidney h+/peptide cotransporter) (solute carrier family 15, member 2). [source:swissprot;acc:q16348]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 185.969\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 165.623\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12285\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 225\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent small nuclear ribonucleoprotein sm d2 (snrnp core protein d2) (sm-d2). [source:swissprot;acc:p43330]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 226.471\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 201.769\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12243\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 226\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cartilage oligomeric matrix protein precursor (comp). [source:swissprot;acc:p49747]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 239.991\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 269.238\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12187\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 227\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent thrombospondin 3 precursor. [source:swissprot;acc:p49746]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 239.99\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 269.234\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12186\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 228\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sh2 domain containing 3c; novel sh2-containing protein 3; sh2 domain-containing 3c; likely ortholog of mouse cas/hef1-associated signal transducer. [source:refseq;acc:nm\_005489]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 226.411\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 202.088\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12036\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 229\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent breast cancer antiestrogen resistance 3. [source:refseq;acc:nm\_003567]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 226.401\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 202.094\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.12028\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 230\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cysteine-rich protein 1 (crp1) (crp). [source:swissprot;acc:p21291]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 239.35\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 267.915\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11934\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 231\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent likely ortholog of mouse shc sh2-domain binding protein 1. [source:refseq;acc:nm\_024745]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 239.336\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 267.881\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11927\vspace{3pt}}\\\cline{1-2}\cline{4-5} \parbox{\wcA}{\vspace{3pt}\noindent 232\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent smooth muscle cell lim protein (cysteine-rich protein 2) (crp2) (lim-only protein 5). [source:swissprot;acc:q16527]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 267.879\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11926\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 233\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent lim domain protein, cardiac (muscle lim protein) (cysteine-rich protein 3) (crp3). [source:swissprot;acc:p50461]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 239.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 267.842\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11918\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 234\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent chromatin accessibility complex protein 1 (chrac-1) (chrac-15) (huchrac15) (dna polymerase epsilon subunit p15). [source:swissprot;acc:q9nrg0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 287.41\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 256.835\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11905\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 235\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phenylalanine-4-hydroxylase (ec 1.14.16.1) (pah) (phe-4- monooxygenase). [source:swissprot;acc:p00439]\vspace{3pt}}&\multirow{10}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 227.357\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 254.15\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11785\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 236\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pp3111 protein. [source:refseq;acc:nm\_022156]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 237\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent syntaxin 18. [source:swissprot;acc:q9p2w9]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 238\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rd protein. [source:swissprot;acc:p18615]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 239\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent glutathione transferase omega 1 (ec 2.5.1.18) (gsto 1-1). [source:swissprot;acc:p78417]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 240\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent androgen-induced 1; cgi-103 protein; androgen induced protein. [source:refseq;acc:nm\_016108]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 241\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atp synthase b chain, mitochondrial precursor (ec 3.6.3.14). [source:swissprot;acc:p24539]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 242\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent j domain containing protein 1. [source:swissprot;acc:q9ukb3]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 243\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sorting nexin 13 (rgs domain- and phox domain-containing protein) (rgs-px1). [source:swissprot;acc:q9y5w8]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 244\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ba127l20.1 (novel glutathione-s-transferase). [source:sptrembl;acc:q9h4y5]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 245\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent small nuclear ribonucleoprotein sm d3 (snrnp core protein d3) (sm-d3). [source:swissprot;acc:p43331]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 226.109\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 202.333\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11751\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 246\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 4 gamma, 3. [source:refseq;acc:nm\_003760]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 237.312\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.363\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11748\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 247\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rna-binding protein. [source:refseq;acc:nm\_019027]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 237.302\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 212.41\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11719\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 248\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent apobec-1 complementation factor isoform 1; apobec-1 stimulating protein; apo-b rna editing protein. [source:refseq;acc:nm\_014576]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 249\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ns1-associated protein 1. [source:refseq;acc:nm\_006372]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 250\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent heterogeneous nuclear ribonucleoprotein r (hnrnp r). [source:swissprot;acc:o43390]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 251\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent oligopeptide transporter, small intestine isoform (peptide transporter 1) (intestinal h+/peptide cotransporter) (solute carrier family 15, member 1). [source:swissprot;acc:p46059]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 186.172\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 166.661\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11707\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 252\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 4 gamma (eif-4-gamma) (eif- 4g) (eif4g) (p220). [source:swissprot;acc:q04637]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 237.292\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 212.457\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11689\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 253\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent mad protein (max dimerizer). [source:swissprot;acc:q05195]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 228\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.333\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11583\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 254\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent source of immunodominant mhc-associated peptides; homolog of yeast stt3 gene. [source:refseq;acc:nm\_178862]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 200.691\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 179.88\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11569\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 255\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent oligosaccharyl transferase stt3 subunit homolog (b5) (integral membrane protein 1) (tmc). [source:swissprot;acc:p46977]\vspace{3pt}}&&&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 256\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent max interacting protein 1 (mxi1 protein). [source:swissprot;acc:p50539]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 227.999\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 204.357\vspace{3pt}}&\\\cline{1-4} \parbox{\wcA}{\vspace{3pt}\noindent 257\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kda subunit precursor (ec 2.4.1.119) (oligosaccharyl transferase 48 kda subunit) (ddost 48 kda subunit). [source:swissprot;acc:p39656]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 200.691\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 179.88\vspace{3pt}}&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/